Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies

Cancer

Volumn 95, Issue 10, 2002, Pages 2152-2159

  Miyamoto, Ryozo ^a   Uzawa, Narikazu ^a   Nagaoka, Shunya ^a   Nakakuki, Koichi ^a   Hirata, Yasushi ^a   Amagasa, Teruo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cyclin D1 gene (CCND1); Fine needle aspiration (FNA); Fluorescence in situ hybridization (FISH); Oral carcinoma

Indexed keywords

CYCLIN D1;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER CELL; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CHROMOSOME 11Q; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037110672     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10929     Document Type: Article

References (39)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med. 1993;328:184-194.
2. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA. 2002;52:23-47.
3. International Union Against Cancer. TNM Classification of Malignant Tumours. 5th Ed. NY: Wiley-Liss, 1997:1-50.
4. Suita S, Zaizen Y, Kaneko M, et al. What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese Study Group for the Treatment of Advanced Neuroblastoma. J Pediatr Surg. 1994;29:746-750.
5. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313:1111-1116.
6. Nakagawara A, Ikeda K, Tsuda T, Higashi K. N-myc oncogene amplification and prognostic factors of neuroblastoma in children. J Pediatr Surg. 1987;22:895-898.
7. Kitagawa Y, Ueda M, Ando N, Shirozawa Y, Shimizu N, Abe O. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res. 1991;51:1504-1508.
8. Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, Levine PA. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1993;119:1238-1243.
9. Muller D, Millon R, Velten M, et al. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: Correlation with clinical outcome. Eur J Cancer. 1997;33:2203-2210.
10. Meredith SD, Levine PA, Burns JA, et al. Chromosome 11q13 amplification in head and neck squamous cell carcinoma: Association with poor prognosis. Arch Otolaryngol Head Neck Surg. 1995;121:790-794.
11. Mori M, Tokino T, Yanagisawa A, et al. Association between chromosome 11q13 amplification and prognosis of patients with oesophageal carcinomas. Eur J Cancer. 1992;28A:755-757.
12. Bekri S, Adelaide J, Merscher S, et al. Detailed map of a region commonly amplified at 11q13-q14 in human breast carcinoma. Cytogenet Cell Genet. 1997;79:125-131.
13. Berenson JR, Yang J, Mickel RA. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene. 1989;4:1111-1116.
14. Roelofs H, Schuuring E, Wiegant J, Michalides R, Giphart-Gassler M. Amplification of the 11q13 region in human carcinoma cell lines: A mechanistic view. Genes Chromosomes Cancer. 1993;7:74-84.
15. Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes - A review. Gene. 1995;159:83-96.
16. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal pattern of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 1995;55:949-956.
17. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T. Oncogene activity of cyclin D1 revealed through cooperation with H-ras: Link between cell cycle control and malignant transformation. Oncogene. 1994;9:323-326.
18. Jiang W, Kahn SM, Tomita N, et al. Altered expression of the cyclin D1 and the retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA. 1993;90:9026-9030.
19. Quelle DE, Ashmun RA, Shurtleff SA, et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 1993;7:1559-1571.
20. Asano K, Sakamoto H, Sasaki H, et al. Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells. Biochem Biophys Res Commun. 1995;217:1169-1176.
21. Callender T, El-Nagger AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer. 1994;74:152-158.
22. Jares P, Fernandez PL, Campo E, et al. PPAD1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994;54:4813-4817.
23. Bellacosa A, Almadori G, Cavallo S, et al. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: Prognostic significance and clinical implications. Clin Cancer Res. 1996;2:175-180.
24. Kyomoto R, Kumazawa H, Toda Y, et al. Cyclin-D1-gene amplificaiton is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous cell carcinoma. Int J Cancer. 1997;74:576-581.
25. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of head and neck. Cancer Res. 1995;55:975-978.
26. Akervall JA, Michalides RJ, Mineta H, et al. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer. 1997;79:380-389.
27. Kuo MYP, Lin CY, Hahn LJ, Cheng SJ, Chiang CP. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J Oral Pathol Med. 1999;28:165-169.
28. Lam KY, Ng IOL, Yuen APW, Kwong DLW, Wei W. Cyclin D1 expression in oral squamous cell carcinomas: Clinicopathological relevance and correlation with p53 expression. J Oral Pathol Med. 2000;29:167-172.
29. Tkakahashi S, Qian J, Brown JA, et al. Potential marker of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res. 1994;54:3574-3579.
30. Ichikawa D, Hashimoto N, Hoshima M, et al. Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer. Cancer. 1996;77:2064-2069.
31. World Health Organization. International Histological Classification of Tumours, 2nd Edition. Berlin: Springer-Verlag, 1988.
32. Jacobsson PA, Eneroth GM, Killander D, Moeberger G, Martenssen B. A histological classification and grading of malignancy in carcinoma of larynx. Acta Radiol. 1973;12:1-18.
33. Yamamoto E, Kohama G, Sunakawa H, Iwai M, Hiratsuka H. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer. 1983;51:2175-2180.
34. Izzo JG, Papadimitrakopoulou VA, Li QX, et al. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: In vivo evidence for an association with subsequent gene amplification. Oncogene. 1998;17:2313-2322.
35. Almasan A, Linke SP, Paulson TG, Huang LC, Wahl GM. Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer Metastasis Rev. 1995;14:59-73.
36. Arato-Ohshima T, Sawa H. Over-expression of cyclin D1 induced glioma invasion by increasing matrix metalloproteinase activity and cell motility. Int J Cancer. 1999;83:387-392.
37. Schuuring E, Verhoeven E, Litvinov S, Michalides RJ. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol Cell Biol. 1993;13:2891-2898.
38. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene. 1992;7:355-361.
39. Brookes S, Lammie GA, Schuuring E, et al. Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3, including the expressed gene EMS1. Genes Chromosomes Cancer. 1993;6:222-231.